Stefanie Granado, Ph.D., is Head of EUCAN for the Oncology Business Unit. Prior to this role, she served as General Manager, Iberia (Spain & Portugal), and was responsible for the Spanish and Portuguese Country organization, overseeing 240 people and more than 50 products, and drove the region’s integration of the Shire team and portfolio. Stefanie has extensive pharmaceutical, healthcare and management consulting experience and has a proven track record in emerging and developed markets, ranging from rare disease to vaccines and generics, and has lived and worked in Latin America, Spain, Switzerland, West Africa and the US.
Prior to this role, Stefanie was Cluster Head of Iberia and General Manager, Spain, at legacy Shire and was a member of the organization’s Europe Leadership Team. Before that, she held various roles of increasing responsibility at Novartis Vaccines and Novartis International AG, as well as at the Boston Consulting Group.
Stefanie holds a Master of Arts degree in Anthropology from the University of Basel, Switzerland, and a Ph.D. in Cultural Epidemiology from the Swiss Tropical and Public Health Institute.